L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy

Purpose: Several studies evidenced the potential of L1CAM as a prognostic marker in endometrial cancer. The aim of this study was to investigate whether L1CAM can predict lymph node metastasis and could therefore be used preoperatively to identify patients with low to high-intermediate risk endometr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeiter, Deborah, Vlajnic, Tatjana, Schötzau, Andreas, Heinzelmann-Schwarz, Viola, Montavon, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489141/
https://www.ncbi.nlm.nih.gov/pubmed/34659530
http://dx.doi.org/10.7150/jca.59283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489141/
https://www.ncbi.nlm.nih.gov/pubmed/34659530
http://dx.doi.org/10.7150/jca.59283

Ejemplares similares